Tanja D. de Gruijl
Vrije Universiteit Amsterdam
H-index: 74
Europe-Netherlands
Top articles of Tanja D. de Gruijl
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The penile cancer tumor microenvironment and immunotherapy response: Results from the PERICLES trial | Cancer Research | Tynisha S Rafael Alberto Gil-Jimenez Hielke M de Vries Iris M Seignette Elise Bekers | 2024/3/22 |
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease | Journal for Immunotherapy of Cancer | Jason J Luke Diwakar Davar Robert H Andtbacka Nina Bhardwaj Joshua D Brody | 2024 |
10.04 Spatial transcriptomics identifies metabolic dysregulation as a key driver of T cell exclusion in esophageal adenocarcinoma | J Sanders EN Bos N Hahn I Nijman HWM van Laarhoven | 2024/3/1 | |
Spatial proteomic analysis of a lung cancer model reveals regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses | bioRxiv | Megan Cole Panayiotis Anastasiou Claudia Lee Chris Moore Edurne Mugarza | 2024 |
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells | Pharmaceutics | Aram M de Haas Dorian A Stolk Sjoerd TT Schetters Laura Goossens-Kruijssen Eelco Keuning | 2024/5 |
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung … | Journal for Immunotherapy of Cancer | Johanna EE Pouw Sayed MS Hashemi Marc C Huisman Jessica E Wijngaarden Maarten Slebe | 2024 |
Single domain antibodies targeting cd1d | 2023/2/28 | ||
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single … | The Lancet Gastroenterology & Hepatology | Florentine EF Timmer Bart Geboers Alette H Ruarus Laurien GPH Vroomen Evelien AC Schouten | 2024/5/1 |
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma | Lindsay VM Leek Jessica CL Notohardjo Karlijn de Joode Eline L Velker John BAG Haanen | 2024/2/23 | |
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations | Frontiers in Immunology | Tessa S Groen-van Schooten Micaela Harrasser Jens Seidel Emma N Bos Tania Fleitas | 2024/4/4 |
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer … | Clinical and Experimental Immunology | EC Toffoli AA van Vliet C Forbes AJ Arns HWM Verheul | 2024/2/8 |
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy | Angiogenesis | Patrycja Nowak-Sliwinska Judy R van Beijnum Christian J Griffioen Zowi R Huinen Nadine Grima Sopesens | 2023/5 |
A bispecific γδ T-cell engager targeting EGFR activates a potent Vγ9Vδ2 T cell–mediated immune response against EGFR-expressing tumors | Cancer immunology research | Lisa A King Elisa C Toffoli Myrthe Veth Victoria Iglesias-Guimarais Manon C Slot | 2023/9/1 |
Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001 | HemaSphere | Luca LG Janssen Theresia M Westers Jeroen Rovers Peter JM Valk Jacqueline Cloos | 2023/11/1 |
A bispecific T cell engager recruits both type 1 NKT and Vy9V52-T cells for the treatment of CD1d-expressing hematological malignancies | Cell Reports Medicine | Roeland Lameris Jurjen M Ruben Victoria Iglesias-Guimarais M de Jong Myrthe Veth | 2023/3/21 |
OA06. 04 Surgery after Neoadjuvant Immuno-Chemoradiotherapy in (Borderline) Resectable NSCLC: Results from the INCREASE Trial | Journal of Thoracic Oncology | C Dickhoff D Heineman F Schneiders I Houda J Veltman | 2023/11/1 |
Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells | Iscience | Amanda A van Vliet Ella Peters Denise Vodegel Daniëlle Steenmans Monica Raimo | 2023/7/21 |
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and … | Journal for Immunotherapy of Cancer | Elisa C Toffoli Amanda A van Vliet Henk WM Verheul Hans J van der Vliet Jurriaan Tuynman | 2023 |
1303P Immune-modulating effects on tumor draining lymph nodes following neoadjuvant chemoradiotherapy combined with immunotherapy in patients with T3-4N0-1 NSCLC | Annals of Oncology | EB Ulas A Vrijmoet S Koomen I Houda C Dickhoff | 2023/10/1 |
Immunoglobulins binding human vgamma9vdelta2 t cell receptors | 2023/7/6 |
Co-Authors
